Stephan Spahn

Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Protocol-Based Management of Severe Fetomaternal Hemorrhage (1.6 g/dL Hb) Allowing Term Vaginal Delivery.

Protocol-Based Management of Severe Fetomaternal Hemorrhage (1.6 g/dL Hb) Allowing Term Vaginal Delivery.

Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)
Published: February 10, 2026

Clinician and medical scientists in internal medicine: gastroenterology

Clinician and medical scientists in internal medicine: gastroenterology

Journal: Innere Medizin (Heidelberg, Germany)
Published: February 05, 2026

Placental Histiocyte Phenotypes in Chronic Histiocytic Intervillositis: A Comprehensive Immunophenotypic and Morphologic Atlas.

Placental Histiocyte Phenotypes in Chronic Histiocytic Intervillositis: A Comprehensive Immunophenotypic and Morphologic Atlas.

Journal: International journal of molecular sciences
Published: January 18, 2026

Lenvatinib after progression on pemigatinib and futibatinib in FGFR2 fusion-positive biliary tract cancer with an acquired kinase point mutation.

Lenvatinib after progression on pemigatinib and futibatinib in FGFR2 fusion-positive biliary tract cancer with an acquired kinase point mutation.

Journal: The oncologist
Published: August 18, 2025

Lack of SLC26A9-mediated chloride secretion causes mucus plugging and severe respiratory distress in neonatal mice.

Lack of SLC26A9-mediated chloride secretion causes mucus plugging and severe respiratory distress in neonatal mice.

Journal: JCI insight
Published: June 02, 2025

The prospective sonographic assessment of the lower uterine segment after cesarean section and its clinical utility.

The prospective sonographic assessment of the lower uterine segment after cesarean section and its clinical utility.

Journal: Archives of gynecology and obstetrics
Published: November 30, 2024

Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion.

Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion.

Journal: Frontiers in oncology
Published: November 13, 2024

Unveiling Clinical Relevance: Investigating Placentas Submitted for Histological Examination and Their Correlation with Clinical Indications and Histological Findings.

Unveiling Clinical Relevance: Investigating Placentas Submitted for Histological Examination and Their Correlation with Clinical Indications and Histological Findings.

Journal: Life (Basel, Switzerland)
Published: June 28, 2024

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma.

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma.

Journal: Nature communications
Published: February 06, 2023

Comprehensive clinical and virological characterization of three cases of fulminant liver failure owing to HSV1 primary infection.

Comprehensive clinical and virological characterization of three cases of fulminant liver failure owing to HSV1 primary infection.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 10, 2021

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.

Journal: Journal of hepatology
Published: January 14, 2021

Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma.

Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma.

Journal: NPJ precision oncology
Published: December 18, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026